Affordable Access

Publisher Website

A population-based nested case-control study in taiwan: use of 5α-reductase inhibitors did not decrease prostate cancer risk in patients with benign prostate hyperplasia.

Authors
Type
Published Article
Journal
The oncologist
Publication Date
Volume
17
Issue
7
Pages
986–991
Identifiers
DOI: 10.1634/theoncologist.2011-0464
PMID: 22723508
Source
Medline

Abstract

This population-based nested case-control study suggested that finasteride use may increase prostate and overall cancer risks for patients with BPH. The effects were more prominent for patients using lower doses of finasteride.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F